204078-93-3 Usage
Description
2-(4-Methylperhydro-1,4-diazepin-1-yl)benzonitrile is a chemical compound belonging to the benzonitrile class, characterized by a benzene ring with a cyano (CN) group attached. It features a perhydro-1,4-diazepin-1-yl group, which includes a six-membered ring with one nitrogen atom and one methyl group. 2-(4-Methylperhydro-1,4-diazepin-1-yl)benzonitrile, with the formula C13H16N3, holds potential in the pharmaceutical industry for drug development and in chemical research and synthesis.
Uses
Used in Pharmaceutical Industry:
2-(4-Methylperhydro-1,4-diazepin-1-yl)benzonitrile is used as a chemical intermediate for the development of new drugs, leveraging its unique structural features to contribute to the creation of novel therapeutic agents.
Used in Chemical Research and Synthesis:
In the realm of chemical research, 2-(4-Methylperhydro-1,4-diazepin-1-yl)benzonitrile serves as a valuable compound for studying its properties and exploring its potential applications in various chemical reactions and processes.
Further study and analysis of 2-(4-Methylperhydro-1,4-diazepin-1-yl)benzonitrile's properties and potential applications are necessary to fully understand its capabilities and maximize its utility in these industries.
Check Digit Verification of cas no
The CAS Registry Mumber 204078-93-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,4,0,7 and 8 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 204078-93:
(8*2)+(7*0)+(6*4)+(5*0)+(4*7)+(3*8)+(2*9)+(1*3)=113
113 % 10 = 3
So 204078-93-3 is a valid CAS Registry Number.
InChI:InChI=1/C13H17N3/c1-15-7-4-8-16(10-9-15)13-6-3-2-5-12(13)11-14/h2-3,5-6H,4,7-10H2,1H3
204078-93-3Relevant articles and documents
Method of inhibiting neoplastic cells with imidazoquinazoline derivatives
-
, (2008/06/13)
A method for inhibiting neoplasia, particularly cancerous and precancerous lesions by exposing the affected cells to imidazoquinazoline derivatives.
